Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
16.89
+0.12 (0.72%)
At close: Sep 18, 2026, 4:00 PM EDT
16.84
-0.05 (-0.30%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Crescent Biopharma Employees
Crescent Biopharma had 69 employees as of June 30, 2026. The number of employees increased by 36 or 109.09% compared to the same quarter last year.
Employees
69
Change
36
Growth
109.09%
Revenue / Employee
$172,217
Profits / Employee
-$2,393,101
Market Cap
722.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 69 | 36 | 109.09% |
| Mar 31, 2026 | 55 | 22 | 66.67% |
| Dec 31, 2025 | 44 | - | - |
| Sep 30, 2025 | 41 | - | - |
| Jun 30, 2025 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Pharming Group | 407 |
| DBV Technologies | 170 |
| Aura Biosciences | 113 |
| Verastem | 102 |
| Silence Therapeutics | 88 |
| Zevra Therapeutics | 61 |
| Design Therapeutics | 55 |
CBIO News
- 6 days ago - Crescent Biopharma Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 10 days ago - Crescent Biopharma Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 11 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 17 days ago - Crescent Biopharma to Present at September Investor Conferences - GlobeNewsWire
- 7 weeks ago - Crescent Biopharma reports Q2 EPS (74c), consensus (64c) - TheFly
- 7 weeks ago - Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 weeks ago - Crescent Biopharma Earnings release: Q2 2026 - Filings
- 7 weeks ago - Crescent Biopharma Quarterly report: Q2 2026 - Filings